Drugs / [68Ga]MLN6907
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02056015 | Jun → Sep 2015 | — | Millennium Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [68Ga]MLN6907 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02056015 ↗ |
| Route | Intravenous | “after a single intravenous (IV) administration” NCT02056015 ↗ |